State Street
EVLO

State Street’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

State Street’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,606
Closed -$27.5K – 4764
2023
Q1 		$27.5K Hold
7,606
– – ﹤0.01% 4634
2022
Q4 		$245K Buy
7,606
+1,913
+34% +$75.7K ﹤0.01% 4028
2022
Q3 		$238K Buy
5,693
+985
+21% +$45K ﹤0.01% 4069
2022
Q2 		$199K Sell
4,708
-24,235
-84% -$1.12M ﹤0.01% 4200
2022
Q1 		$1.96M Buy
28,943
+923
+3% +$76.8K ﹤0.01% 3574
2021
Q4 		$3.4M Buy
28,020
+1,103
+4% +$186K ﹤0.01% 3427
2021
Q3 		$3.79M Buy
26,917
+2,428
+10% +$481K ﹤0.01% 3377
2021
Q2 		$6.73M Buy
24,489
+8,413
+52% +$2.12M ﹤0.01% 3108
2021
Q1 		$3.44M Buy
16,076
+1,358
+9% +$375K ﹤0.01% 3206
2020
Q4 		$3.56M Buy
14,718
+1,628
+12% +$201K ﹤0.01% 3127
2020
Q3 		$1.38M Buy
13,090
+1,560
+14% +$142K ﹤0.01% 3341
2020
Q2 		$1.13M Buy
11,530
+31
+0.3% +$2.71K ﹤0.01% 3387
2020
Q1 		$864K Buy
11,499
+50
+0.4% +$4.76K ﹤0.01% 3338
2019
Q4 		$930K Buy
11,449
+376
+3% +$42.1K ﹤0.01% 3421
2019
Q3 		$1.35M Buy
11,073
+13
+0.1% +$1.79K ﹤0.01% 3339
2019
Q2 		$1.99M Buy
11,060
+816
+8% +$132K ﹤0.01% 3244
2019
Q1 		$1.64M Buy
10,244
+1,890
+23% +$374K ﹤0.01% 3222
2018
Q4 		$2.17M Buy
8,354
+3,550
+74% +$714K ﹤0.01% 3086
2018
Q3 		$1.17M Buy
4,804
+2,664
+124% +$697K ﹤0.01% 3380
2018
Q2 		$505K Buy
+2,140
New +$624K ﹤0.01% 3466

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street's EVLO Position: Q2 2023 in Review

State Street sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2023, closing a stake of 7,606 shares — an estimated $27.5K sold.

State Street first reported a position in EVLO in Q2 2018 and held it in 20 quarters. The position peaked at $6.73M in Q2 2021. 25 funds tracked by Wall St. Rank hold EVLO as of Q2 2023.

  • State Street reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • State Street sold 7,606 Evelo Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $27.5K.
  • State Street first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 20 quarters.
  • State Street's Evelo Biosciences, Inc. Common Stock position peaked at $6.73M in Q2 2021.
  • 25 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.